Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1998
10/15/1998WO1998045263A1 Analogs of cocaine
10/15/1998WO1998045259A2 Polyaromatic antiviral compositions
10/15/1998WO1998045257A1 Thio derivatives as naaladase inhibitors
10/15/1998WO1998045256A1 Hydroxamic acid derivatives
10/15/1998WO1998045255A1 Calcilytic compounds
10/15/1998WO1998045253A1 Activated iododerivatives for the treatment of cancer and aids
10/15/1998WO1998045250A1 Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate
10/15/1998WO1998045249A1 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same
10/15/1998WO1998045242A1 Retinoid activity regulators
10/15/1998WO1998045241A2 Lutein esters having high bioavailability
10/15/1998WO1998045230A1 Chromatographic enantiomer separation of lactones
10/15/1998WO1998044955A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
10/15/1998WO1998044953A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998WO1998044952A1 pH-SELECTIVE DELIVERY SYSTEM USING CROSS-LINKED POLYMERIC RESINS AS VEHICLES
10/15/1998WO1998044947A1 Allergen formulation
10/15/1998WO1998044940A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998WO1998044932A1 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals
10/15/1998WO1998044930A1 Povidone iodine (pvp-i) alcohol gel antimicrobial pre-operative skin preparation
10/15/1998WO1998044929A1 Composition comprising a hydrolysed collagen protein and glucosamine for the treatment of arthroses
10/15/1998WO1998044928A1 NKT CELL ACTIVATORS CONTAINING α-GLYCOSYLCERAMIDES
10/15/1998WO1998044927A1 Method of treating and preventing gallstones
10/15/1998WO1998044926A1 Antimicrobial compositions
10/15/1998WO1998044925A1 Calcilytic compounds
10/15/1998WO1998044924A1 Method for treating depression, obsessive compulsive disorder or anxiety
10/15/1998WO1998044923A1 Anti-neoplastic effects of actinonin
10/15/1998WO1998044922A1 Somatostatin agonists
10/15/1998WO1998044921A1 Somatostatin agonists
10/15/1998WO1998044920A1 Use of halo and/or nitro-substituted flavonoids as anxyolitics
10/15/1998WO1998044919A1 Use of aminothiolester derivatives in pharmaceutics
10/15/1998WO1998044918A1 Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
10/15/1998WO1998044917A1 Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
10/15/1998WO1998044916A1 Preventives and remedies for ulcerous colitis and/or crohn's disease
10/15/1998WO1998044915A1 In vivo polymerizable ophthalmic compositions
10/15/1998WO1998044914A1 Compositions for the treatment of burns and external ulcers and a process for the preparation thereof
10/15/1998WO1998044913A2 Compositions containing mkc-442 in combination with other antiviral agents
10/15/1998WO1998044904A1 Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein
10/15/1998WO1998044902A1 Compositions comprising santalins, santarubins for artificially coloring the skin
10/15/1998WO1998044893A2 Method and formulation for treating vascular disease
10/15/1998WO1998044808A2 PROCESS FOR ENHANCING IMMUNE RESPONSE IN ANIMALS USING β-CAROTENE AS A DIETARY SUPPLEMENT
10/15/1998WO1998044799A1 Diarylsulfonylureas for use in treating secretory diarrhea
10/15/1998WO1998044797A1 A method of treating cancer
10/15/1998WO1998044796A1 Method for treating hypertension
10/15/1998WO1998044794A1 Compositions and methods for skin disinfection employing mandelic acid
10/15/1998WO1998029134A3 Microporation of tissue for delivery of bioactive agents
10/15/1998WO1998029105A3 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
10/15/1998WO1998024806A3 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
10/15/1998WO1998024421A3 Use of dextrin sulphate for the treatment of highly vascular tumours
10/15/1998WO1998020864A3 Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases
10/15/1998DE19715504A1 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen PMMA membranes with polyethylene glycol-coupled active substances
10/15/1998DE19714875A1 First aid kit for prophylaxis of blood-borne infections e.g. HIV or hepatitis in e.g. police and medical or laboratory staff
10/15/1998DE19714343A1 Chromatographische Enantiomerentrennung von Lactonen Chromatographic separation of the enantiomers of lactones
10/15/1998CA2665949A1 Vinca alkaloid antimitotic halogenated derivatives
10/15/1998CA2287778A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998CA2287293A1 Somatostatin agonists
10/15/1998CA2287084A1 Diagnosis method and reagents
10/15/1998CA2286860A1 Radioisotope concentrator methods and compositions
10/15/1998CA2286457A1 Estra-5(10),7-dienes with estrogenic activity
10/15/1998CA2286455A1 Treatment of central nervous system disorders with selective estrogen receptor modulators
10/15/1998CA2286454A1 Calcilytic compounds
10/15/1998CA2286452A1 Pyrimido-isoquinoline compounds with anticonvulsive action
10/15/1998CA2286305A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
10/15/1998CA2286303A1 20 human secreted proteins
10/15/1998CA2286264A1 Insulin-like growth factor agonist peptides
10/15/1998CA2286239A1 A method of treating cancer
10/15/1998CA2286207A1 Prevention of breast cancer with selective estrogen receptor modulators
10/15/1998CA2286204A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/15/1998CA2286186A1 Activated iododerivatives for the treatment of cancer and aids
10/15/1998CA2285960A1 Use of lactoferin in the treatment of allergen induced disorders
10/15/1998CA2285906A1 Hydroxamic acid derivatives
10/15/1998CA2285679A1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same
10/15/1998CA2285640A1 Compositions comprising santalins, santarubins for artificially coloring the skin
10/15/1998CA2285604A1 Somatostatin agonists
10/15/1998CA2285577A1 Compositions containing mkc-442 in combination with other antiviral agents
10/15/1998CA2285556A1 Calcilytic compounds
10/15/1998CA2285454A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998CA2285388A1 Compounds
10/15/1998CA2285336A1 Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein
10/15/1998CA2285287A1 Antiviral protease inhibitors
10/15/1998CA2285223A1 Somatostatin agonists
10/15/1998CA2285192A1 Pharmacological agents
10/15/1998CA2284996A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
10/15/1998CA2284922A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998CA2284682A1 Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
10/15/1998CA2283718A1 Crystalline amine salt of cefdinir
10/15/1998CA2281843A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove
10/15/1998CA2272625A1 In vivo polymerizable ophthalmic compositions
10/15/1998CA2257500A1 Antimicrobial compositions
10/15/1998CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor
10/14/1998EP0870768A1 Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
10/14/1998EP0870764A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/14/1998EP0870761A1 Thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
10/14/1998EP0870760A1 Cyclopropyl glycine derivatives with pharmaceutical properties
10/14/1998EP0870759A1 Aminated 6,7,8,9-tetrahydro-cyclopenta[a]naphtalene- and 2,3-dihydro-cyclopenta[e]indene-derivatives, process for their preparation and pharmaceutical compsitions containing them
10/14/1998EP0870757A2 Fluoro-substituted adamantane derivatives
10/14/1998EP0870510A2 Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents
10/14/1998EP0870505A1 Use of d-allose as an immunosuppressive agent
10/14/1998EP0870504A2 New compositions comprising biologically active silicon
10/14/1998EP0870503A1 Malignant tumor metastasis inhibitors
10/14/1998EP0870502A2 Use of adenosine uptake inhibitors for the manufacture of a medicament for the treatment of pancreatitis
10/14/1998EP0870501A1 Use of specific cryptophycin derivatives for the manufacture of a medicament in the treatment of fungal infections
1 ... 6594 6595 6596 6597 6598 6599 6600 6601 6602 6603 6604 6605 6606 6607 6608 6609 6610 6611 6612 6613 6614 ... 7860